Hepatitis C In The News

Hepatitis C News

Week Ending August 29, 2010

PSI-7977 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
“Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for PSI-7977 for the treatment of chronic hepatitis C virus (HCV) infection.”

Mayo RT Fired After Possible Hep C Infection
“Mayo Clinic in Jacksonville, Fla., has fired a licensed radiologic technologist (RT), who was a possible source of transmission of Hepatitis C infection to three transplant patients.”

Hepatitis C virus infection in Brazilian long-distance truck drivers
“Hepatitis C virus (HCV) infection is a global public health problem. Long-distance truck drivers live apart from their family for long periods of time, a lifestyle that favors at-risk behaviors such as unprotected sex with multiple partners and illicit drug use.”

ZymoGenetics completes enrolment in phase 2b trial with PEG-Interferon lambda & ribavirin in chronic hepatitis C
“ZymoGenetics, Inc. announced enrolment has been completed in the phase 2b clinical trial with PEG-Interferon lambda and ribavirin in chronic hepatitis C virus (HCV) infection. ZymoGenetics is investigating PEG-Interferon lambda in collaboration with Bristol-Myers Squibb Company for the treatment of HCV infection.”

Hepatitis C Virus Infections Among HIV-Infected Men Who Have Sex With Men: An Expanding Epidemic
“Since 2000, outbreaks of sexually transmitted hepatitis C virus have been reported among HIV-positive men who have sex with men (MSM). In the current study, the authors conclude that the prevalence of HCV in this population is "high and increasing."”

LabCorp launches genetic test for hepatitis C therapy reaction
BURLINGTON, N.C. – “Laboratory Corporation of America (NYSE: LH) is rolling out a new genetic test designed to determined a person’s reaction to some hepatitis C virus therapies.”

For more Hepatitis C In The News, click here

Hep C Discussion Point™

The Caring Ambassadors Hepatitis C Program is pleased to announce the launch of Hep C Discussion Point™ a question-and-answer survey to help you manage your health while living with hepatitis C.

Hep C Discussion Point™ is a series of questions about your experience living with and managing hepatitis C. You simply answer the questions, and a customized list of information (discussion points) is produced to help you and your health care providers work together to maximize your health.

Hep C Discussion Point™ was designed by the Caring Ambassadors Hepatitis C Program along with a team of medical advisors. Hep C Discussion Point™ is an easy way to learn more about how best to work with your doctors to improve or maintain your health while living with hepatitis C.

After you’ve tried Hep C Discussion Point™, please provide your suggestions and comments by answering a few short questions.

The Caring Ambassadors Hepatitis C Program thanks the National Hepatitis C Advocacy Council for funding support aiding in the development of Hep C Discussion Point™.

Click here to enter Hep C Discussion Point™.

Partner Showcase

RUNHELPLIVE
"Because You Can"
5k Run/Walk
In honor of Donald and Barbara Kinsala
Date: October 16, 2010
View PDF Flyer

Caring Ambassadors Program Webinar Series

Now Available: Leveraging the IOM Report

The Caring Ambassadors Program in partnership with the National Viral Hepatitis Roundtable and Hepatitis C Advocates United is pleased to announce our new Webinar series. Each month we will be hosting an interactive educational webinar on viral hepatitis. We hope you will actively participate as we collectively augment our knowledge base from experts in the field.

Early diagnosis is essential to control spread of HCV.